FDA Grants De Novo Request for Neuromodulatory System for Urge Incontinence

(MedPage Today) -- The FDA has granted a de novo marketing request for the Revi System for tibial neuromodulation to treat urinary incontinence with or without urinary urgency, BlueWind Medical announced on Thursday. The de novo request allows...
Source: MedPage Today OB/GYN - Category: OBGYN Source Type: news